Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Eric S. Schaefer
Proactive Management Strategies for Potential Gastrointestinal Adverse Reactions With Ceritinib in Patients With Advanced ALK-positive Non-Small-Cell Lung Cancer
Cancer Management and Research
Oncology
Related publications
Treating Patients With ALK-positive Non-Small Cell Lung Cancer: Latest Evidence and Management Strategy
Therapeutic Advances in Medical Oncology
Oncology
Ceritinib Plus Nivolumab in Patients With Advanced ALK-rearranged Non-Small-Cell Lung Cancer: Results of an Open-Label, Multicenter, Phase 1B Study
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Successful Rechallenge With Ceritinib After Leukocytoclastic Vasculitis During Ceritinib Treatment for Non-Small Cell Lung Cancer Harboring the EML4-ALK Fusion Protein
Oncotarget
Oncology
Chinese Perspectives on Clinical Efficacy and Safety of Alectinib in Patients With ALK-positive Advanced Non-Small Cell Lung Cancer
OncoTargets and Therapy
Oncology
Pharmacology
Chemoradiotherapy Followed by Durvalumab in Patients With Unresectable Advanced Non‐small Cell Lung Cancer: Management of Adverse Events
Thoracic Cancer
Medicine
Pulmonary
Respiratory Medicine
Oncology
Management of Patients With Advanced Non-Small Cell Lung Cancer: Role of Gefitinib
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
174P: Comparison of Cardiovascular Effects of Crizotinib and Chemotherapy in Patients (Pts) With ALK-positive (+) Advanced Non-Small Cell Lung Cancer (NSCLC)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Circadian Function in Patients With Advanced Non-Small-Cell Lung Cancer
British Journal of Cancer
Cancer Research
Oncology
Efficacy and Safety of Crizotinib Among Chinese EML4-ALK-Positive, Advanced-Stage Non-Small Cell Lung Cancer Patients
PLoS ONE
Multidisciplinary
